Murray Cod Australia (MCA) H2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2025 earnings summary
27 Mar, 2026Executive summary
Achieved a net profit after tax of $8.56 million for FY25, reversing a prior year loss of $6.22 million, driven by strong operational execution and increased sales of premium Murray cod.
Revenue from ordinary activities rose 2.6% year-over-year to $10.85 million, with EBITDA surging 808% to $18.61 million.
Biological stock value more than doubled to $67.83 million, reflecting significant investment in biomass and infrastructure.
Major expansion at the Stanbridge site increased production capacity, supporting future growth and consistent supply.
No dividends were paid or recommended for the year.
Financial highlights
Revenue increased 2.6% year-over-year to $10.85 million.
Net profit after tax was $8.56 million, up from a $6.22 million loss in FY24.
EBITDA reached $18.61 million, up 808% from the previous year.
Net tangible assets per share rose to $0.97 from $0.08.
Biological asset value increased by $35.78 million to $67.83 million.
Outlook and guidance
Focus on converting increased biomass into cash through expanded sales and marketing efforts.
Continued investment in operational capacity and infrastructure to support scaling production.
Strategic emphasis on domestic market strength before accelerating international expansion.
Anticipated further growth in export markets, particularly in Asia, the Middle East, North America, and Europe.
Latest events from Murray Cod Australia
- Revenue up 40% year-over-year, but net loss of $4.1 million driven by higher costs.MCA
H1 20268 Mar 2026 - Record profit, infrastructure scale-up, and all resolutions passed, setting up FY26 growth.MCA
AGM 202518 Nov 2025 - Sales up 45% year-over-year, with expanded retail footprint and strong export growth.MCA
Q1 2026 TU27 Oct 2025 - Record profitability and a $17m capital raise position the business for premium market growth.MCA
Investor Presentation25 Sep 2025 - Record profitability and biomass growth set the stage for accelerated sales and cash generation in FY26.MCA
Investor Presentation23 Sep 2025 - Revenue up 22% and record biomass set, driven by premium pricing and export growth.MCA
H2 202413 Jun 2025 - Net profit swung to $1.33m as revenue, biological assets, and export channels expanded.MCA
H1 20255 Jun 2025